Immix Biopharma (IMMX) Other Non-Current Assets (2022 - 2026)

Immix Biopharma has reported Other Non-Current Assets for 5 years, with the latest figure at $20418.0 in Q1 2026.

• Quarterly Other Non-Current Assets changed 0.0% year-over-year to $20418.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $20418.0 (changed 0.0% YoY) and the FY2025 annual result came in at $20418.0, changed 0.0% from the prior year.
• Other Non-Current Assets steadied at $20418.0 in Q1 2026 per IMMX's latest filing, from $20418.0 in the prior quarter.
• Over five years, Other Non-Current Assets peaked at $175131.0 in Q1 2023 and troughed at $6724.0 in Q4 2022.
• A 5-year average of $40425.5 and a median of $20418.0 in 2024 frame the typical range for Other Non-Current Assets.
• The sharpest annual moves came in 2024 and 2025: Other Non-Current Assets slumped 88.34% in 2024, then changed 0.0% in 2025.
• Over 5 years, Other Non-Current Assets stood at $6724.0 in 2022, then jumped by 1434.67% to $103191.0 in 2023, then tumbled by 80.21% to $20418.0 in 2024, then changed by 0.0% to $20418.0 in 2025, then changed by 0.0% to $20418.0 in 2026.
• According to Business Quant data, Other Non-Current Assets over the past three periods registered $20418.0, $20418.0, and $20418.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.